http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33556303

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 1287
issn 0007-1188
1476-5381
issueIdentifier 6
pageRange 1281-1287
publicationName British Journal of Pharmacology
startingPage 1281
bibliographicCitation Chou TC, Lin YF, Wu WC, Chu KM. Enhanced nitric oxide and cyclic GMP formation plays a role in the anti-platelet activity of simvastatin. Br J Pharmacol. 2008 Mar;153(6):1281–7. PMID: 18264124; PMCID: PMC2275444.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b45cab410ec33d398a30adc167afdc6c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_beb3cae1923e6e21b6c0d186533a4c2d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2feaa703f9f651fe00ba82b10e73a807
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27e649a004a9f33ff4fd2cbe1627cda0
date 200803
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2275444
https://doi.org/10.1038/bjp.2008.19
https://pubmed.ncbi.nlm.nih.gov/18264124
isPartOf https://portal.issn.org/resource/ISSN/0007-1188
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1895
https://portal.issn.org/resource/ISSN/1476-5381
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Enhanced nitric oxide and cyclic GMP formation plays a role in the anti‐platelet activity of simvastatin
discusses http://id.nlm.nih.gov/mesh/M0029425
http://id.nlm.nih.gov/mesh/M0017012
http://id.nlm.nih.gov/mesh/M0023237
http://id.nlm.nih.gov/mesh/M0009695
http://id.nlm.nih.gov/mesh/M0014877
http://id.nlm.nih.gov/mesh/M0004775
http://id.nlm.nih.gov/mesh/M0009685
http://id.nlm.nih.gov/mesh/M0028375
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D010975Q000494
http://id.nlm.nih.gov/mesh/D019821Q000494
http://id.nlm.nih.gov/mesh/D006152Q000378
http://id.nlm.nih.gov/mesh/D010974Q000187
hasSubjectTerm http://id.nlm.nih.gov/mesh/D009569Q000378
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D011817
http://id.nlm.nih.gov/mesh/D019001Q000187
http://id.nlm.nih.gov/mesh/D019001Q000378
http://id.nlm.nih.gov/mesh/D003094Q000187
http://id.nlm.nih.gov/mesh/D010975Q000008
http://id.nlm.nih.gov/mesh/D015106Q000187
http://id.nlm.nih.gov/mesh/D019821Q000008
http://id.nlm.nih.gov/mesh/D003094Q000378
http://id.nlm.nih.gov/mesh/D020128
http://id.nlm.nih.gov/mesh/D015106Q000378
http://id.nlm.nih.gov/mesh/D006162Q000378
http://id.nlm.nih.gov/mesh/D006162Q000187
http://id.nlm.nih.gov/mesh/D066298
http://id.nlm.nih.gov/mesh/D004305
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444899
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_4.6.1.2
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145068
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.1.4.1

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129200050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129166007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129872283

Total number of triples: 65.